Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2023 Earnings Call Transcript August 14, 2023
Acurx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $0.29.
Operator: Greetings, and welcome to the Acurx Pharmaceuticals to discuss Second Quarter 2023 Financial Results and Business Update. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator Instructions] As a...
